Top February 2022 FDA Drug Approvals
February 2022 FDA drug approvals include treatments for bacterial vaginosis, COVID-19, spasticity, and cold agglutinin.
Diagnosis & Disease Information
Top January 2022 FDA Drug Approvals
January 2022 FDA drug approvals include treatments for asthma, psoriatic arthritis, insomnia, and atopic dermatitis.
Top November & December 2021 FDA Approvals
November and December 2021 FDA drug approvals include treatments for hepatitis B, achondroplasia, cancer, and polycythemia vera.
Top October 2021 FDA Approvals
The October approvals include treatments for acute pain, opioid overdose, dry eye disease, and COVID-19 vaccine for children 5 to 11 years of age.
Top August & September 2021 FDA Approvals
August and September 2021 FDA drug approvals include treatments for tick-borne encephalitis, idiopathic hypersomnia, schizophrenia, and atopic dermatitis.
Top July 2021 FDA Approvals
July 2021 FDA drug approvals include treatments for T2D in adolescents, trichomoniasis, and acne vulgaris, as well as a vaccine for pneumococcal diseases.
Top June 2021 FDA Approvals
June 2021 FDA drug approvals include treatments for smallpox, weight loss, candidiasis, and Alzheimer disease.
WHO to Test, Approve Generic Insulin
Agency says new generic versions could create competition that would drive down prices.
Zerbaxa Approved for Hospital-Acquired Bacterial Pneumonia
Drug previously approved for treatment of complicated intra-abdominal infections, UTIs.
FDA Approves Venetoclax for Chronic Lymphocytic Leukemia
In randomized trial, drug demonstrated statistically significant improvement in progression-free survival.
- Loading...
Loading...
Next post in Hematology/Oncology Information Center
Loading... 
Loading...